$2.1 BILLION PHARMA SETTLEMENT. Teva and Sun Pharma will pay $2.15 billion to settle a patent suit related to its acid-reflux drug. “This is the first instance of generic drugmakers paying damages for marketing a copy of an existing drug for which patents have yet to expire (an ‘at-risk’ launch).”
“”It is an important milestone, setting a ‘book-end’ case for the industry. It will serve to encourage patent settlements,” ”
”
http://lnkd.in/dHi9MEX
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022